Equities

Rua Life Sciences PLC

RUA:LSE

Rua Life Sciences PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)11.00
  • Today's Change0.00 / 0.00%
  • Shares traded225.84k
  • 1 Year change-67.65%
  • Beta0.9452
Data delayed at least 20 minutes, as of Jul 05 2024 15:55 BST.
More ▼

Profile data is unavailable for this security.

About the company

RUA Life Sciences plc is a United Kingdom-based holding company of a group of medical device businesses focused on the exploitation of long-term implantable biostable polymer (Elast-Eon). Elast-Eon's biostability is comparable to silicone while exhibiting excellent mechanical, blood contacting and flex-fatigue properties. The Company has four business units: RUA Contract Manufacture, RUA Biomaterials, RUA Vascular and RUA Structural Heart. RUA Contract Manufacture is an end-to-end contract developer and manufacturer of medical devices and implantable fabric specialist. It provides sub-contract manufacturing, assembly, packing and services to the medical device sector from its Class 7 and 8 cleanroom suites. RUA Biomaterials is a licensor of Elast-Eon polymers to the medical device industry. RUA Vascular is engaged in the commercialization of open surgical vascular grafts and patches. RUA Structural Heart is engaged in the development of polymeric leaflet systems for heart valves.

  • Revenue in GBP (TTM)1.87m
  • Net income in GBP-1.87m
  • Incorporated1996
  • Employees40.00
  • Location
    Rua Life Sciences PLC2 Drummond Crescent, IrvineAYRSHIRE KA11 5ANUnited KingdomGBR
  • Phone+44 12 9431 7073Fax+44 19 3225 1113
  • Websitehttps://rualifesciences.com/
More ▼

Peer analysis

CompanyRevenue (TTM)Net income (TTM)Market capEmployeesMarket Cap /
Employees
Truspine Technologies PLC0.00-471.89k2.68m1.002.68m1.00
Image Scan Holdings Plc2.56m-11.06k2.74m14.002.74m14.00
Deltex Medical Group plc1.78m-1.28m2.84m37.002.84m37.00
Aptamer Group PLC1.04m-7.01m3.15m54.003.15m54.00
Surgical Innovations Group Plc12.01m-509.00k5.13m101.005.13m101.00
Myhealthchecked PLC10.98m-159.00k5.20m10.005.20m10.00
Rua Life Sciences PLC1.87m-1.87m6.83m40.006.83m40.00
Cambridge Nutritional Sciences PLC9.05m-3.21m8.69m91.008.69m91.00
Feedback plc886.00k-3.49m9.13m24.009.13m24.00
Genedrive PLC272.00k-5.00m9.37m43.009.37m43.00
Data as of Jul 05 2024. Currency figures normalised to Rua Life Sciences PLC's reporting currency: UK Pound GBX

Institutional shareholders

16.43%Per cent of shares held by top holders
HolderShares% Held
Dowgate Capital Ltd.as of 18 Dec 20236.03m9.72%
Rathbones Investment Management Ltd.as of 19 Dec 20234.13m6.66%
Unicorn Asset Management Ltd.as of 30 Jun 202433.61k0.05%
Data from 31 Mar 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.